Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225731045> ?p ?o ?g. }
- W4225731045 endingPage "2021" @default.
- W4225731045 startingPage "00556" @default.
- W4225731045 abstract "Obstructive airway disease (OAD), which includes COPD and asthma, is the leading cause of morbidity and mortality in India. Long-acting bronchodilators (long-acting β2 agonists (LABAs) and/or long-acting muscarinic antagonists (LAMAs)) and inhaled corticosteroids (ICS) have a vital role in the management of patients with OAD. While symptom burden and exacerbations are common amongst treated patients, poor adherence to inhaler therapy is a frequent challenge. Better treatment options that optimise symptom control, improve quality of life, reduce exacerbation risk and improve adherence are desired. Triple therapy (ICS/LABA/LAMA) is recommended in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021 guidelines for symptomatic COPD patients on ICS/LABA or LABA/LAMA, and who are at increased risk for frequent or severe exacerbations. Similarly, add-on LAMA is recommended in uncontrolled asthma patients on medium- to high-dose ICS/LABA by the Global Initiative for Asthma (GINA) 2021 guideline. In the real world, high-risk and overlapping phenotypes exist, which necessitate early initiation of triple therapy. We aim to provide an expert review on the use of single-inhaler triple therapy (SITT) for OAD management in global and Indian settings, knowledge from which can be extrapolated for appropriate treatment of Indian patients. The OAD population in India may benefit from early optimisation to SITT characterised by a high burden of exacerbating OAD, nonsmoker COPD and asthma–COPD overlap." @default.
- W4225731045 created "2022-05-05" @default.
- W4225731045 creator A5001157636 @default.
- W4225731045 creator A5031211495 @default.
- W4225731045 creator A5044886651 @default.
- W4225731045 creator A5046066094 @default.
- W4225731045 creator A5063890369 @default.
- W4225731045 creator A5070489582 @default.
- W4225731045 creator A5073227636 @default.
- W4225731045 creator A5079746705 @default.
- W4225731045 creator A5080910293 @default.
- W4225731045 date "2022-01-01" @default.
- W4225731045 modified "2023-10-18" @default.
- W4225731045 title "Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts’ review" @default.
- W4225731045 cites W1987881697 @default.
- W4225731045 cites W2002726093 @default.
- W4225731045 cites W2016698284 @default.
- W4225731045 cites W2028482424 @default.
- W4225731045 cites W2071671062 @default.
- W4225731045 cites W2101978351 @default.
- W4225731045 cites W2140841197 @default.
- W4225731045 cites W2169104840 @default.
- W4225731045 cites W2313458055 @default.
- W4225731045 cites W2324038222 @default.
- W4225731045 cites W2431068257 @default.
- W4225731045 cites W2513086234 @default.
- W4225731045 cites W2520266823 @default.
- W4225731045 cites W2592322635 @default.
- W4225731045 cites W2604743750 @default.
- W4225731045 cites W2610956233 @default.
- W4225731045 cites W2761298511 @default.
- W4225731045 cites W2765326832 @default.
- W4225731045 cites W2765602348 @default.
- W4225731045 cites W2769489485 @default.
- W4225731045 cites W2785999277 @default.
- W4225731045 cites W2797560548 @default.
- W4225731045 cites W2800792064 @default.
- W4225731045 cites W2802221596 @default.
- W4225731045 cites W2810354106 @default.
- W4225731045 cites W2884305124 @default.
- W4225731045 cites W2889606340 @default.
- W4225731045 cites W2890588650 @default.
- W4225731045 cites W2891482814 @default.
- W4225731045 cites W2894623749 @default.
- W4225731045 cites W2896540195 @default.
- W4225731045 cites W2899919480 @default.
- W4225731045 cites W2909220707 @default.
- W4225731045 cites W2912650333 @default.
- W4225731045 cites W2912675200 @default.
- W4225731045 cites W2912977997 @default.
- W4225731045 cites W2914798425 @default.
- W4225731045 cites W2917119057 @default.
- W4225731045 cites W2925576446 @default.
- W4225731045 cites W2937106071 @default.
- W4225731045 cites W2948650018 @default.
- W4225731045 cites W2955571440 @default.
- W4225731045 cites W2964478340 @default.
- W4225731045 cites W2973599255 @default.
- W4225731045 cites W2975622327 @default.
- W4225731045 cites W2977394198 @default.
- W4225731045 cites W2980400988 @default.
- W4225731045 cites W2983026434 @default.
- W4225731045 cites W2989252965 @default.
- W4225731045 cites W2993723754 @default.
- W4225731045 cites W2999846874 @default.
- W4225731045 cites W3003546074 @default.
- W4225731045 cites W3004146263 @default.
- W4225731045 cites W3004930970 @default.
- W4225731045 cites W3008261882 @default.
- W4225731045 cites W3012701098 @default.
- W4225731045 cites W3015750388 @default.
- W4225731045 cites W3016201212 @default.
- W4225731045 cites W3021885641 @default.
- W4225731045 cites W3033244535 @default.
- W4225731045 cites W3033438356 @default.
- W4225731045 cites W3037411127 @default.
- W4225731045 cites W3040817145 @default.
- W4225731045 cites W3041578668 @default.
- W4225731045 cites W3045136116 @default.
- W4225731045 cites W3081703149 @default.
- W4225731045 cites W3083130978 @default.
- W4225731045 cites W3084377968 @default.
- W4225731045 cites W3089618257 @default.
- W4225731045 cites W3093184096 @default.
- W4225731045 cites W3093211622 @default.
- W4225731045 cites W3095068028 @default.
- W4225731045 cites W3095804563 @default.
- W4225731045 cites W3096169406 @default.
- W4225731045 cites W3097151741 @default.
- W4225731045 cites W3109451132 @default.
- W4225731045 cites W3120383455 @default.
- W4225731045 cites W3120737064 @default.
- W4225731045 cites W3121660159 @default.
- W4225731045 cites W3127614400 @default.
- W4225731045 cites W3136999494 @default.
- W4225731045 cites W3168208924 @default.
- W4225731045 cites W3176205343 @default.
- W4225731045 cites W4231520868 @default.